WK Cancer Treatement Center

Clinical Trials

Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase

Purpose

To compare the efficacy of 2 different treatments in patients with Chronic Phase CML as measured by major molecular response (MMR) rate at 12 months.

Criteria 

  • Male or female patients ≥ 18 years old 
  • Newly diagnosed , within 6 months of diagnosis with Chronic Phase CML 
  • Not received any prior treatment for Chronic Phase CML

Details

  • Subjects will be followed every Cycle on Days 1,8,15,28. 
  • Treatment medication will be provided.

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at (318) 212-8671.